Revolutionising cellular therapies for cancer and beyond

We’re developing more precise and more accessible treatment options for patients with solid cancers, endometriosis and Alzheimer’s disease

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

Supporting Science

By Christine Filippis / May 11, 2020
Cartherics answers the coronavirus call By Leigh Dayton, Cartherics Communications Advisor The global COVID-19 pandemic affects all Australians, their friends...
Read More

Cartherics Salutes World Ovarian Cancer Day – 8 May 2020

By Christine Filippis / May 7, 2020
A message from Cartherics’ CEO Alan Trounson In Australia, one woman loses her battle with ovarian cancer every eight hours....
Read More

Natural Killer Cell Therapies Catch Up to CAR T

By Christine Filippis / April 29, 2020
There’s a new cell-based cancer immunotherapy on the block. When the first anticancer therapies based on engineered T cells hit...
Read More